Eli Lilly Cash on Hand 2010-2024 | LLY

Eli Lilly cash on hand for the quarter ending September 30, 2024 was $3.518B, a 41.08% increase year-over-year.

  • Eli Lilly cash on hand for 2023 was $2.928B, a 32.37% increase from 2022.
  • Eli Lilly cash on hand for 2022 was $2.212B, a 43.41% decline from 2021.
  • Eli Lilly cash on hand for 2021 was $3.909B, a 6.17% increase from 2020.

Eli Lilly Cash on Hand 2010-2024 | LLY

  • Eli Lilly cash on hand for 2023 was $2.928B, a 32.37% increase from 2022.
  • Eli Lilly cash on hand for 2022 was $2.212B, a 43.41% decline from 2021.
  • Eli Lilly cash on hand for 2021 was $3.909B, a 6.17% increase from 2020.
Related Stocks
Company NameMarket
Cap
Novo Nordisk (NVO)$472.8B
Johnson & Johnson (JNJ)$380.1B
AbbVie (ABBV)$355.5B
Merck (MRK)$255.1B
Novartis AG (NVS)$218.3B
AstraZeneca (AZN)$198B
Pfizer (PFE)$155B
Sanofi (SNY)$130.1B
Innoviva (INVA)$1.2B